Hereditary  	Hereditary  	 JJ	B-NP
angioedema 	angioedema 	 NN	I-NP
:  	:  	 :	O
a  	a  	 DT	O
case  	case  	 NN	O
of  	of  	 IN	O
near  	near  	 JJ	O
fatal  	fatal  	 JJ	B-NP
laryngeal  	laryngeal  	 NNS	I-NP
swelling  	swelling  	 VBG	O
in  	in  	 IN	O
a  	a  	 DT	O
41-year-old  	41-year-old  	 JJ	O
woman  	woman  	 NN	O
Hereditary  	Hereditary  	 FW	B-NP
angioedema  	angioedema  	 FW	I-NP
( 	( 	 -LRB-	O
HAE 	HAE 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
nonpitting 	nonpitting 	 NN	B-NP
,  	,  	 ,	O
nonpruritic  	nonpruritic  	 JJ	B-NP
subcutaneous 	subcutaneous 	 NN	I-NP
,  	,  	 ,	O
or  	or  	 CC	O
submucosal  	submucosal  	 JJ	B-NP
edema  	edema  	 NN	I-NP
that  	that  	 WDT	O
may  	may  	 MD	O
be  	be  	 VB	O
accompanied  	accompanied  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
nonpruritic  	nonpruritic  	 JJ	B-NP
serpentine  	serpentine  	 JJ	I-NP
erythematous  	erythematous  	 JJ	I-NP
rash 	rash 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
swelling  	swelling  	 NN	O
in  	in  	 IN	O
this  	this  	 DT	O
autosomal  	autosomal  	 JJ	O
dominantly  	dominantly  	 NN	O
inherited  	inherited  	 VBD	B-NP
disorder  	disorder  	 NN	I-NP
is  	is  	 VBZ	O
mediated  	mediated  	 VBN	O
by  	by  	 IN	O
uncontrolled  	uncontrolled  	 JJ	O
localized  	localized  	 JJ	O
bradykinin  	bradykinin  	 JJ	B-NP
production 	production 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
extremities 	extremities 	 NN	O
,  	,  	 ,	O
face 	face 	 NN	O
,  	,  	 ,	O
gastrointestinal  	gastrointestinal  	 JJ	B-NP
tract 	tract 	 NN	I-NP
,  	,  	 ,	O
genitalia 	genitalia 	 NN	B-NP
,  	,  	 ,	O
larynx 	larynx 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
trunk  	trunk  	 NNS	O
are  	are  	 VBP	O
commonly  	commonly  	 RB	O
involved 	involved 	 VBN	O
.  	.  	 .	O
Nearly  	Nearly  	 RB	O
one-third  	one-third  	 JJ	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
are  	are  	 VBP	O
not  	not  	 RB	O
treated  	treated  	 VBN	O
may  	may  	 MD	O
suffer  	suffer  	 VB	O
asphyxiation  	asphyxiation  	 VBN	B-NP
from  	from  	 IN	O
a  	a  	 DT	O
laryngeal  	laryngeal  	 JJ	B-NP
attack 	attack 	 NN	I-NP
.  	.  	 .	O
HAE  	HAE  	 NNP	B-NP
symptoms  	symptoms  	 NNS	I-NP
overlap  	overlap  	 VBP	O
with  	with  	 IN	O
other  	other  	 JJ	O
conditions  	conditions  	 NNS	O
that  	that  	 WDT	O
cause  	cause  	 VBP	O
swelling 	swelling 	 VBG	O
.  	.  	 .	O
An  	An  	 DT	O
accurate  	accurate  	 JJ	O
diagnosis  	diagnosis  	 NN	O
is  	is  	 VBZ	O
therefore  	therefore  	 RB	O
crucial  	crucial  	 JJ	O
when  	when  	 WRB	O
considering  	considering  	 VBG	B-NP
therapy 	therapy 	 NN	I-NP
.  	.  	 .	O
Recently  	Recently  	 RB	O
approved  	approved  	 VBN	B-NP
treatments  	treatments  	 NNS	I-NP
for  	for  	 IN	I-NP
HAE  	HAE  	 NNP	I-NP
swelling  	swelling  	 VBG	I-NP
attacks  	attacks  	 NNS	I-NP
include  	include  	 VBP	O
C1  	C1  	 RB	O
esterase  	esterase  	 JJ	B-NP
inhibitor  	inhibitor  	 JJ	I-NP
concentrate  	concentrate  	 NN	I-NP
and  	and  	 CC	O
ecallantide 	ecallantide 	 NN	B-NP
.  	.  	 .	O
This  	This  	 DT	O
case  	case  	 NN	O
describes  	describes  	 VBZ	O
a  	a  	 DT	O
41-year-old  	41-year-old  	 JJ	O
woman  	woman  	 NN	O
who  	who  	 WP	O
was  	was  	 VBD	O
treated  	treated  	 VBN	O
ineffectively  	ineffectively  	 VBN	O
for  	for  	 IN	O
more  	more  	 JJR	O
than  	than  	 IN	O
20  	20  	 CD	O
years 	years 	 NNS	O
,  	,  	 ,	O
was  	was  	 VBD	O
switched  	switched  	 VBN	O
to  	to  	 TO	O
an  	an  	 DT	O
effective  	effective  	 JJ	O
therapy 	therapy 	 NN	O
,  	,  	 ,	O
but  	but  	 CC	O
suffered  	suffered  	 VBN	O
near  	near  	 IN	O
fatal  	fatal  	 JJ	B-NP
laryngeal  	laryngeal  	 NNS	I-NP
edema  	edema  	 VBP	O
due  	due  	 JJ	O
to  	to  	 TO	O
a  	a  	 DT	O
missed  	missed  	 JJ	O
dose  	dose  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
effective  	effective  	 JJ	O
therapy 	therapy 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
case  	case  	 NN	O
underscores  	underscores  	 VBZ	O
the  	the  	 DT	O
need  	need  	 NN	O
for  	for  	 IN	O
increased  	increased  	 JJ	O
awareness  	awareness  	 NN	O
of  	of  	 IN	O
HAE  	HAE  	 NNP	B-NP
among  	among  	 IN	O
clinicians  	clinicians  	 NN	B-NP
and  	and  	 CC	O
the  	the  	 DT	O
importance  	importance  	 NN	O
of  	of  	 IN	O
good  	good  	 JJ	O
compliance  	compliance  	 NN	O
to  	to  	 TO	O
therapy  	therapy  	 NN	O
among  	among  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
HAE 	HAE 	 NNP	B-NP
.  	.  	 .	O
